The Valley Desk

ArticleAdvances in therapyPublished

BRIDGE-2M: Optimizing Bridging Therapy Prior to CAR-T Therapy in Multiple Myeloma: A Modified Double-Blind Delphi Panel of US Physicians

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
Advances in therapy
Published
Subject terms
Multiple myeloma; Bridging Therapy; Car T-cell Therapy; Idecabtagene Vicleucel; Talquetamab; Ciltacabtagene Autoleucel
PubMed ID
42618714
Added to directory
Source checked

Report a correction or request removal